porcin
adenoviru
padv
mani
qualiti
make
ideal
choic
use
deliveri
vector
swine
low
grade
pathogen
present
almost
worldwid
number
serotyp
vari
virul
tissu
tropism
may
allow
serotyp
specif
vaccin
target
padv
speci
specif
isol
swine
reduc
possibl
spread
anim
man
follow
administr
engin
contain
foreign
gene
recombin
padv
rpadv
grown
high
titr
tissu
cultur
cell
make
cheap
produc
knowledg
complet
nucleotid
sequenc
padv
genom
enabl
ration
direct
insert
foreign
gene
remain
stabli
insert
genom
express
high
level
follow
deliveri
target
host
importantli
recombin
padv
administ
inject
oral
rout
feed
drink
water
deliv
rang
antigen
immunomodulatori
molecul
commerci
avail
pig
use
rpadv
found
effect
deliveri
system
significantli
recombin
padv
serotyp
highli
effect
deliveri
vehicl
even
administ
face
high
level
artifici
induc
serotyp
specif
neutralis
antibodi
vector
adenovirus
nonenvelop
icosahedr
virus
diamet
nm
genom
fig
consist
linear
doublestrand
dna
vari
kilobas
pair
kbp
depend
upon
speci
review
see
shenk
adenoviru
famili
recent
divid
four
genera
mastadeno
atadeno
aviadeno
siadenovirus
pringl
van
regenmortel
et
al
uchenosmond
mastadenovirus
infect
mammal
aviadenovirus
infect
avian
speci
howev
specif
member
third
fourth
genera
shown
infect
either
mammal
bird
amphibian
reptil
analysi
genom
arrang
dna
sequenc
data
brought
recent
distinct
atadeno
siadenovirus
bovin
adenoviru
bav
serotyp
ovin
adenoviru
oav
isol
egg
drop
syndrom
ed
viru
includ
atadeno
genu
frog
adenoviru
turkey
adenoviru
place
siadenoviru
genu
harrach
et
al
uchenosmond
porcin
adenoviru
padv
first
isol
pig
england
haig
et
al
sinc
presenc
padv
swine
demonstr
virtual
worldwid
viru
isol
serolog
survey
derbyshir
depend
upon
serotyp
padv
grown
pig
kidney
testi
retina
thyroid
cell
human
kidney
canin
melanoma
calf
kidney
cell
dea
elazhari
kasza
veterinari
journal
mayr
et
al
least
five
serotyp
padv
circul
domest
pig
popul
intern
clark
et
al
derbyshir
et
al
nagi
et
al
two
serotyp
appar
identifi
japan
kadoi
kadoi
et
al
porcin
adenoviru
regard
low
grade
pathogen
domest
pig
caus
mild
diarrhoea
short
durat
clinic
sign
regularli
associ
infect
notabl
also
isol
appar
healthi
pig
clinic
diseas
derbyshir
et
al
mahnel
bibrack
rasmussen
sinc
infect
padv
asymptomat
pig
consid
econom
import
pig
industri
porcin
adenoviru
isol
swine
host
describ
probabl
husbandri
practic
maintain
product
pig
close
contact
may
facilit
mainten
padv
herd
via
faecalor
transmiss
porcin
adenoviru
classifi
within
genu
mastadenoviru
adenovirida
famili
nonenvelop
icosahedr
viru
particl
contain
doublestrand
dna
genom
approxim
kbp
restrict
enzym
map
sequenc
analysi
serotyp
demonstr
padv
close
relat
padv
less
similar
distinct
human
murin
canin
bovin
fowl
adenovirus
garw
xuan
kleiboek
nagi
et
al
reddi
et
al
reddi
et
al
recombin
human
adenovirus
utilis
extens
viral
vector
human
vaccin
deliveri
gene
therapi
berkner
kovesdi
et
al
miller
addit
human
adenoviru
hav
serotyp
recombin
express
spike
glycoprotein
gp
porcin
respiratori
coronaviru
prcv
shown
induc
immun
respons
foreign
antigen
pig
callebaut
et
al
callebaut
et
al
subsequ
adenovirus
isol
speci
man
gener
increas
interest
deliveri
system
use
anim
man
recombin
bovin
mittal
et
al
ovin
xu
et
al
canin
klonjkowski
et
al
fowl
sheppard
et
al
porcin
adenovirus
describ
use
rang
speci
specif
deliveri
vaccin
antigen
cattl
chicken
dog
pig
deliveri
cancer
therapeut
human
babiuk
tikoo
fischer
et
al
hammond
et
al
johnson
et
al
voek
et
al
comparison
abil
potenti
viral
vector
stimul
immun
respons
pig
tuboli
et
al
show
padv
could
induc
system
mucos
antibodi
respons
combin
observ
demonstr
could
induc
immun
respons
foreign
antigen
pig
mu
direct
transcript
indic
arrow
insert
site
foreign
gene
shown
doublehead
arrow
e
earli
l
late
mlp
major
late
promot
tpl
tripartit
leader
insert
site
rhe
righthand
end
insert
site
prepar
nucleotid
sequenc
transcript
inform
reddi
et
al
hammond
et
al
anticip
padv
would
prove
effect
speci
specif
vector
deliveri
varieti
molecul
swine
construct
test
number
recombin
padv
vector
express
antigen
immunomodulatori
molecul
cytokin
outbr
commerci
avail
pig
result
studi
other
present
review
laboratori
recombin
padv
construct
insert
foreign
gene
righthand
end
padv
genom
fig
express
foreign
gene
direct
viral
major
late
promot
mlp
strongest
adenovir
promot
porcin
adenoviru
mlp
tripartit
leader
tpl
sequenc
requir
direct
high
level
foreign
gene
express
clone
insert
padv
express
vector
foreign
gene
express
insert
element
polya
signal
sequenc
express
cassett
insert
righthand
end
padv
genom
homolog
recombin
correct
orient
confirm
polymeras
chain
reaction
pcr
use
method
delet
padv
genom
made
result
product
fulli
replic
compet
recombin
viru
may
import
consider
recombin
use
outbr
swine
may
prior
exposur
padv
insert
made
first
rpadv
includ
gene
classic
swine
fever
viru
increas
genom
length
wild
type
exceed
expect
maximum
insert
size
stabl
mastadeno
viru
recombin
almost
even
larger
recombin
padv
sinc
construct
total
genom
size
howev
prior
insert
foreign
genet
materi
case
portion
genom
delet
thu
contain
largest
stabl
insert
made
nondelet
mastadeno
viru
recombin
far
report
earli
region
padv
utilis
insert
site
construct
recombin
virus
follow
prior
delet
viral
dna
sequenc
reddi
et
al
reddi
et
al
tuboli
et
al
well
known
open
read
frame
present
region
human
adenovirus
requir
viral
replic
vitro
thought
play
major
role
evas
host
antivir
immun
respons
russel
thu
delet
region
padv
recombin
could
significantli
alter
abil
vector
replic
vivo
consequ
compromis
abil
success
express
foreign
gene
also
foreign
gene
far
insert
padv
region
coupl
specif
padv
promot
element
reli
sole
upon
endogen
padv
promot
express
use
mlp
may
essenti
high
level
gene
express
broad
time
period
requir
sinc
promot
function
earli
overwhelm
later
viral
replic
cycl
shenk
reddi
et
al
b
construct
version
helper
depend
independ
vector
helper
independ
replic
compet
vector
contain
gene
pseudorabi
viru
prv
construct
insert
gd
code
sequenc
partial
delet
region
reddi
et
al
vaccin
trial
recombin
viru
pig
describ
hammond
et
al
helper
depend
vector
construct
delet
region
insert
place
report
gene
green
fluoresc
protein
gfp
control
cytomegaloviru
immedi
earli
promot
subsequ
rescu
recombin
viru
particl
growth
porcin
cell
line
express
protein
recombin
shown
express
gfp
gene
expect
unabl
replic
swine
tissu
cultur
cell
without
provis
complement
gene
human
adenoviru
region
vector
may
use
vaccin
strategi
express
gene
product
requir
spread
vector
within
host
undesir
specif
target
gene
therapi
applic
nontarget
speci
rather
swine
anim
studi
yet
publish
use
vector
tuboli
et
al
construct
recombin
padv
serotyp
express
portion
gene
transmiss
gastroenter
viru
tgev
although
abl
produc
recombin
viru
stabli
express
full
length
code
sequenc
kb
recombin
viru
contain
kb
fragment
gene
shown
express
truncat
product
tissu
cultur
administ
oral
pig
serum
mucos
antibodi
respons
protein
detect
sadli
howev
tgev
challeng
experi
report
therefor
protect
data
avail
classic
swine
fever
viru
gene
classic
swine
fever
viru
csfv
infect
pig
result
acut
fatal
diseas
mortal
suscept
popul
classic
swine
fever
highli
contagi
distribut
almost
worldwid
consid
econom
import
diseas
swine
area
intens
pig
farm
dahl
liess
first
demonstr
padv
effect
vector
deliveri
vaccin
antigen
swine
singl
dose
recombin
padv
express
singl
gene
csfv
strain
shown
protect
pig
csfv
challeng
experi
outbr
commerci
avail
larg
white
pig
given
singl
dose
recombin
viru
monitor
daili
advers
reaction
vaccin
follow
vaccin
pig
display
clinic
diseas
temperatur
remain
normal
abil
thrive
unimped
recent
also
found
vaccin
viru
reisol
time
administr
passag
mucos
swab
materi
tissu
cultur
unpublish
observ
challeng
subcutan
sc
dose
csfv
lethal
suscept
anim
vaccin
pig
protect
csf
wherea
control
pig
develop
sever
clinic
sign
euthanas
unvaccin
control
pig
develop
fever
temperatur
rise
day
post
challeng
remain
high
euthanas
sever
diseas
vaccin
pig
apart
brief
rise
temperatur
day
remain
complet
free
diseas
termin
experi
postmortem
intern
sign
csf
lesion
could
found
spleen
vaccin
anim
shown
free
csfv
antigen
elisa
wherea
control
pig
high
level
csfv
antigen
experi
demonstr
csfv
challeng
viru
could
reisol
vaccin
group
pig
hammond
et
al
suggest
use
potenti
reduc
prevent
common
problem
csfv
shed
vaccin
follow
challeng
anoth
vaccin
strategi
gener
lot
interest
recent
primeboost
regim
suscept
target
anim
given
one
dose
vaccin
compris
exampl
foreign
gene
express
nake
dna
plasmid
dna
vaccin
follow
second
booster
dose
express
gene
via
differ
deliveri
system
recombin
viru
ramsay
et
al
regim
shown
prime
immun
system
respond
greater
degre
follow
administr
booster
dose
two
dose
deliv
via
rout
andor
vector
primeboost
vaccin
regim
recombin
shown
highli
effect
boost
immun
respons
follow
initi
prime
dna
base
vaccin
significantli
improv
level
protect
diseas
given
singl
dose
dna
vaccin
alon
hammond
et
al
inde
primeboost
regim
complet
abrog
transient
increas
temperatur
observ
challeng
pig
vaccin
singl
dose
alon
two
dose
dna
vaccin
recent
experi
utilis
contact
csf
challeng
model
design
reproduc
infect
like
seen
field
experiment
infect
pig
put
close
contact
vaccin
unvaccin
control
swine
one
two
dose
day
apart
administ
commerci
avail
outbr
pig
either
sc
oral
suscept
csf
determin
control
pig
given
lethal
dose
csfv
unvaccin
contact
pig
develop
sever
diseas
euthanas
pig
vaccin
sc
either
singl
two
dose
develop
diseas
protect
contact
challeng
pig
given
two
dose
sc
also
develop
substanti
csfv
specif
serum
neutralis
antibodi
prior
challeng
contrast
pig
given
singl
oral
dose
vaccin
develop
clinic
csf
euthanas
howev
signific
observ
work
pig
given
two
oral
dose
complet
protect
diseas
even
though
develop
csfv
specif
serum
neutralis
antibodi
prior
challeng
hammond
et
al
johnson
et
al
result
add
weight
argument
immun
mechan
apart
serum
neutralis
antibodi
oper
protect
csf
previous
suggest
hammond
et
al
result
also
demonstr
padv
base
vaccin
effect
deliv
either
inject
oral
rout
pseudorabi
viru
prv
alpha
herpesviru
caus
econom
import
widespread
diseas
ajd
pig
mettenleit
highli
neurotrop
caus
nervou
respiratori
complic
pig
natur
host
varieti
anim
speci
kluge
et
al
mulder
et
al
anticip
develop
live
recombin
rpadvprv
vaccin
would
provid
safe
altern
live
prv
vaccin
sinc
infecti
maintain
problem
associ
live
herp
viru
vector
revers
virul
andor
latenc
kluge
et
al
mulder
et
al
gd
gene
prv
insert
region
reddi
et
al
result
recombin
viru
rpadvgd
test
vaccin
trial
determin
protect
challeng
prv
hammond
et
al
five
week
old
commerci
avail
larg
white
pig
given
either
singl
dose
two
dose
rpadvgd
day
apart
pig
monitor
develop
serum
neutral
antibodi
prv
challeng
three
week
final
vaccin
none
pig
show
advers
reaction
vaccin
prior
challeng
pig
given
two
dose
develop
higher
level
prv
specif
serum
neutral
antibodi
given
singl
dose
hammond
et
al
follow
prv
challeng
pig
monitor
clinic
sign
diseas
abil
thrive
condit
record
control
anim
becam
sick
elev
temperatur
six
day
post
challeng
wherea
vaccin
display
increas
temperatur
day
control
pig
given
singl
dose
lost
condit
abil
thrive
impair
group
given
two
dose
remain
healthi
fig
postmortem
gross
lesion
pneumonia
found
lung
control
pig
given
singl
dose
vaccin
lung
pig
given
two
dose
free
diseas
fig
brain
histolog
demonstr
mark
differ
sever
infect
frequenc
antigen
detect
control
singl
dose
group
sever
affect
pig
given
two
dose
least
sinc
gd
gene
specif
link
padv
promot
quit
probabl
protect
ajd
elicit
recombin
could
improv
coupl
gd
gene
mlp
tpl
sequenc
similar
express
system
use
csfv
vaccin
experi
would
expect
increas
level
express
protect
gd
antigen
may
increas
magnitud
immun
respons
follow
success
use
rpadv
deliv
vaccin
antigen
swine
sinc
investig
potenti
rpadv
deliv
therapeut
molecul
porcin
cytokin
outbr
pig
legisl
compulsori
withdraw
use
infe
antibiot
anim
feed
becom
widespread
therefor
becom
necessari
explor
altern
safe
natur
mean
protect
pig
diseas
associ
intens
farm
practic
reemerg
diseas
problem
associ
free
rang
piggeri
cytokin
natur
mediat
protect
immun
respons
may
ideal
candid
replac
antibiot
anim
feed
blecha
interferon
gamma
ifnc
import
modul
innat
adapt
immun
system
prime
import
activ
tcell
macrophag
therefor
play
pivot
role
gener
protect
immun
respons
mani
viral
bacteri
infect
review
see
samuel
previous
trial
broiler
chicken
recombin
fowl
adenoviru
express
chicken
ifnc
gene
demonstr
treat
bird
show
increas
weight
gain
compar
untreat
control
bird
johnson
et
al
johnson
et
al
interest
determin
whether
treatment
outbr
pig
ifnc
would
show
similar
effect
recombin
porcin
adenoviru
express
porcin
ifnc
gene
construct
rpadvifnc
shown
posit
express
ifnc
bioassay
data
shown
rpadv
test
safeti
trial
design
detect
recombin
viru
shed
vaccin
outbr
pig
recombin
viru
could
reisol
follow
three
serial
passag
nasal
rectal
swab
tissu
cultur
rpadv
dna
detect
padv
specif
pcr
passag
materi
data
shown
first
trial
outbr
five
week
old
wean
pig
inocul
sc
singl
dose
tcid
rpadvifnc
group
control
pig
either
left
untreat
fig
assess
pig
condit
follow
treatment
rpadvgd
overal
condit
pig
assess
score
scale
poor
good
prior
termin
postmortem
lung
examin
diseas
patholog
score
presenc
pneumonia
none
sever
mean
score
treatment
group
shown
percent
valu
untreat
singl
dose
two
dose
given
equival
singl
dose
recombin
padv
control
pig
fed
standard
diet
commerci
avail
medic
feed
weight
record
weekli
mean
weight
group
shown
tabl
second
trial
carri
use
vaccin
regim
experiment
condit
pig
fed
diet
nonmed
feed
contain
ad
antibiot
weight
record
weekli
mean
weight
group
shown
tabl
medic
nonmed
feed
trial
demonstr
treatment
pig
singl
dose
rpadvifnc
result
higher
proport
pig
reach
defin
target
weight
day
approxim
end
postwean
period
control
group
either
untreat
treat
recombin
padv
express
antigen
present
similar
lower
proport
pig
reach
weight
target
great
interest
observ
nonmed
feed
trial
increas
number
pig
reach
target
weight
control
group
statist
analysi
mean
weight
demonstr
increas
signific
p
compar
control
group
data
indic
treatment
pig
one
dose
rpadvifnc
wean
result
signific
weight
gain
end
postwean
period
order
pig
fed
medic
nonmed
feed
import
observ
pig
treat
one
dose
rpadvifnc
similar
growth
rate
throughout
record
period
show
reduc
weight
variat
individu
anim
compar
group
control
implic
observ
pig
treat
rpadvifnc
uniform
growth
rate
reach
target
weight
sooner
untreat
group
larg
scale
studi
requir
determin
potenti
rpadvifnc
use
commerci
piggeri
replac
infe
antibiot
granulocyt
coloni
stimul
factor
gcsf
induc
polymorphonuclear
leukocyt
pmnl
includ
basophil
eosinophil
predominantli
neutrophil
play
vital
role
equip
innat
arm
immun
system
provid
first
line
defenc
pathogen
bacteria
fungi
parasit
hubel
et
al
gcsf
regul
normal
develop
pmnl
direct
matur
function
capac
regist
food
drug
administr
usa
use
human
treat
patient
suffer
neutropenia
caus
immunosuppress
therapi
treatment
anticanc
drug
gcsf
promot
product
pmnl
thu
increas
patient
abil
resolv
associ
bacteri
fungal
infect
recombin
porcin
adenoviru
express
porcin
gcsf
gene
construct
rpadvgcsf
johnson
et
al
construct
also
test
safeti
trial
design
detect
recombin
viru
shed
vaccin
pig
recombin
viru
reisol
follow
three
serial
passag
nasal
rectal
swab
tissu
cultur
rpadv
dna
detect
padv
specif
pcr
passag
materi
data
shown
two
group
six
outbr
old
pig
hous
adjoin
pen
pig
bled
daili
day
day
vaccin
end
experi
day
white
blood
cell
count
record
one
group
vaccin
sc
tcid
rpadvgcsf
day
second
group
six
pig
left
untreat
day
post
vaccin
pig
challeng
intratrach
coloni
form
unitsml
actinobacillu
pleuroneumonia
serovar
app
monitor
daili
clinic
sign
app
postmortem
carri
pig
day
postchalleng
app
lung
lesion
score
record
gener
condit
note
group
control
pig
either
left
untreat
given
equival
singl
dose
recombin
padv
control
test
pig
given
singl
dose
rpadvifnc
treatment
given
day
pig
fed
indic
weight
record
weekli
mean
weight
day
age
group
shown
day
app
challeng
signific
differ
overal
white
blood
cell
wbc
count
untreat
control
pig
vaccin
rpadvgcsf
surprisingli
increas
peripher
blood
neutrophil
number
observ
recombin
treat
group
howev
follow
challeng
app
signific
differ
observ
two
group
fig
control
challeng
pig
demonstr
sharp
increas
peripher
blood
neutrophil
peak
h
post
infect
drop
consider
rose
second
peak
eight
day
post
challeng
remain
high
termin
experi
signific
increas
circul
neutrophil
typic
respons
observ
follow
experiment
infect
pig
app
boss
et
al
contrast
rpadvgcsf
treat
pig
show
delay
sustain
increas
neutrophil
level
peak
h
post
challeng
fig
peak
significantli
lower
control
pig
level
decreas
rise
unlik
untreat
group
fig
percent
chang
white
blood
cell
popul
rpadvgcsf
treat
pig
two
group
six
pig
bled
daili
day
white
blood
cell
count
record
day
one
group
vaccin
subcutan
tcid
rpadvgcsf
pig
bled
daili
day
day
post
vaccin
pig
challeng
intratrach
coloni
form
unitsml
actinobacillu
pleuroneumonia
serovar
trial
termin
day
postchalleng
overal
condit
pig
app
lung
lesion
score
postmortem
record
white
blood
cell
type
follow
total
white
blood
cell
neutrophil
probabl
increas
peripher
blood
neutrophil
level
direct
result
app
challeng
neutrophil
recruit
lung
order
combat
infect
although
histolog
carri
lung
materi
analysi
wbc
popul
peripher
blood
day
daili
bleed
pig
began
demonstr
generalis
daili
fluctuat
across
cell
type
group
howev
treatment
rpadvgcsf
appear
reduc
fluctuat
far
less
variat
wbc
count
observ
day
administr
compar
untreat
control
group
fig
effect
also
observ
follow
challeng
app
increas
wbc
popul
includ
pmnl
less
substanti
tightli
constrain
treat
pig
control
upon
termin
experi
day
post
challeng
condit
pig
record
score
postmortem
pig
examin
presenc
app
lesion
lung
condit
control
pig
poor
wherea
rpadvgcsf
treat
pig
good
condit
show
clinic
sign
diseas
postmortem
control
pig
show
larg
number
lesion
lung
wherea
contrast
pig
treat
rpadvgcsf
significantli
reduc
lesion
load
tabl
comparison
lesionlob
score
moor
et
al
two
group
demonstr
substanti
overal
reduct
clinic
score
rpadvgcsf
treat
group
compar
untreat
control
group
control
pig
given
equival
dose
wild
type
vector
show
signific
reduct
lesionlob
score
compar
untreat
control
data
shown
signific
result
clearli
demonstr
singl
dose
rpadvgcsf
abl
give
consider
protect
sever
experiment
challeng
app
confirm
recombin
padv
express
gcsf
potent
inhibitor
bacteri
infect
app
pig
porcin
adenoviru
thought
ubiquit
swine
popul
around
world
derbyshir
predomin
serotyp
consequ
concern
express
would
suitabl
deliveri
vector
due
potenti
preexist
neutralis
antibodi
swine
interfer
recombin
viru
take
host
padv
isol
pig
queensland
australia
kwon
spradbrow
previous
report
major
pig
use
vaccin
trial
australia
seroposit
neutralis
antibodi
vaccin
vaccin
still
effect
prevent
csf
diseas
anim
hammond
et
al
subsequ
survey
pig
sera
collect
variou
locat
around
australia
shown
singl
dilut
swine
test
specif
serum
neutralis
antibodi
tabl
detail
analysi
group
six
pig
vaccin
subcutan
tcid
rpadvgcsf
day
trial
second
group
left
untreat
day
post
vaccin
pig
challeng
intratrach
coloni
form
unitsml
app
monitor
daili
clinic
sign
diseas
day
post
infect
postmortem
carri
pig
app
lung
lesion
score
record
gener
condit
note
lesion
score
given
percent
per
group
total
n
lesion
score
given
per
pig
per
group
total
diseasen
lobe
score
given
total
lobe
affect
n
lesion
score
pig
serum
variou
state
australia
assay
serum
neutralis
test
presenc
neutralis
antibodi
serum
sampl
test
duplic
dilut
smaller
sampl
set
sera
shown
titr
rang
major
fig
interest
determin
whether
presenc
rais
level
serum
neutralis
antibodi
could
interfer
efficaci
csfv
vaccin
trial
design
address
question
nine
old
larg
white
pig
given
sc
inject
wild
type
order
induc
specif
neutralis
antibodi
pig
low
specif
serum
neutralis
antibodi
titr
padv
start
experi
increas
day
post
administr
subsequ
three
pig
receiv
two
dose
day
post
administr
respect
three
pig
receiv
singl
dose
day
three
pig
left
unvaccin
mean
specif
neutralis
antibodi
titr
sera
pig
given
two
dose
vaccin
time
first
vaccin
day
time
second
vaccin
day
mean
padv
titr
pig
given
singl
dose
day
pig
challeng
classic
swine
fever
day
post
administr
respons
challeng
monitor
three
unvaccin
control
pig
develop
high
fever
relat
clinic
sign
csf
euthanas
fig
pig
singl
dose
group
show
slight
increas
temperatur
day
post
challeng
return
normal
pig
show
sign
csf
exactli
respons
observ
previous
csfv
vaccin
trial
carri
pig
given
hammond
et
al
pig
given
two
dose
develop
fever
show
sign
csf
examin
spleen
challeng
pig
demonstr
presenc
high
level
csfv
antigen
three
control
none
vaccin
addit
pig
given
two
dose
show
specif
boost
level
prechalleng
csfv
neutralis
antibodi
follow
second
dose
vaccin
even
face
specif
neutralis
antibodi
vector
result
clearli
demonstr
recombin
padv
serotyp
extrem
effici
vector
deliveri
vaccin
antigen
swine
efficaci
inhibit
presenc
serotyp
specif
neutralis
antibodi
outbr
pig
taken
togeth
result
studi
strongli
suggest
recombin
porcin
adenoviru
vector
base
upon
serotyp
potenti
highli
effect
deliveri
vehicl
swine
field
wide
varieti
molecul
deliveri
success
achiev
parenter
oral
rout
appear
case
even
administ
presenc
consider
level
specif
neutralis
antibodi
vector
potenti
target
host
use
deliveri
vector
therapeut
molecul
larg
scale
trial
determin
whether
rpadvcytokin
treatment
product
anim
succeed
natur
replac
infe
antibiot
howev
work
strongli
suggest
deliveri
cytokin
gene
recombin
porcin
adenoviru
prove
highli
effect
mechan
introduc
therapot
molecul
